Literature DB >> 21330909

High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients.

Aoife G Cotter1, Claudette S Satchell, Jane A O'halloran, Eoin R Feeney, Caroline A Sabin, Patrick W G Mallon.   

Abstract

We aimed to determine the contribution of high-density lipoprotein cholesterol (HDL-c) to cardiovascular disease (CVD) risk in a cohort of HIV-infected patients. The contribution of CVD risk factors to the predicted CVD risk was assessed. We estimated the degree of reclassification of CVD risk if HDL-c concentration was increased in all patients by 20 and 40%, respectively. After age, HDL-c contributed most to the overall cardiovascular risk. Increasing HDL-c by 20% and 40% reclassified six and 12 patients to lower CVD risk groups, respectively. In this cohort, HDL-c contributed more to cardiovascular risk than smoking, total cholesterol, systolic blood pressure (SBP) and sex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330909     DOI: 10.1097/QAD.0b013e32834507f0

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.

Authors:  Alana M Munger; Dominic C Chow; Martin P Playford; Nisha I Parikh; Louie Mar A Gangcuangco; Beau K Nakamoto; Kalpana J Kallianpur; Lishomwa C Ndhlovu; Cecilia M Shikuma; Nehal N Mehta
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-29       Impact factor: 2.205

2.  Changes in Lipid Profiles of HIV(+) Adults over Nine Months at a Harare HIV Clinic: A Longitudinal Study.

Authors:  Danai Tavonga Zhou; Doreen Nehumba; Olav Oktedalen; Princess Marange; Vitaris Kodogo; Zvenyika Alfred Gomo; Tonya M Esterhuizen; Babill Stray-Pedersen
Journal:  Biochem Res Int       Date:  2016-03-08

3.  Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya.

Authors:  Anne Njoroge; B L Guthrie; Rose Bosire; Mark Wener; James Kiarie; Carey Farquhar
Journal:  Lipids Health Dis       Date:  2017-06-09       Impact factor: 3.876

Review 4.  How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.

Authors:  Anthony Jaworowski; Anna C Hearps; Thomas A Angelovich; Jennifer F Hoy
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

5.  Executable models of immune signaling pathways in HIV-associated atherosclerosis.

Authors:  Mukta G Palshikar; Rohith Palli; Alicia Tyrell; Sanjay Maggirwar; Giovanni Schifitto; Meera V Singh; Juilee Thakar
Journal:  NPJ Syst Biol Appl       Date:  2022-09-21

6.  Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia.

Authors:  Setha Limsreng; Olivier Marcy; Sowath Ly; Vara Ouk; Hak Chanroeurn; Saem Thavary; Ban Boroath; Ana Canestri; Gérald Viretto; Jean-François Delfraissy; Olivier Ségéral
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.